Autolus Therapeutics Ltd reported 123.82M in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
AstraZeneca USD 7.06B 1.83B Jun/2025
Autolus Therapeutics Ltd 123.82M 28.02M Jun/2025
Hikma Pharmaceutical USD 188M 188M Dec/2024
Novartis USD 6.66B 410M Jun/2025
Roche Holding CHF 6.98B 2.15B Dec/2024
Silence Therapeutics 61.95M 47.53M Sep/2024